Chad E Beyer (21 results)

Hardcover. Condition: Fine. 1st Edition. 137 p.

Condition: Very Good. 1st Edition. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Condition: New.

Condition: New. The future of mood-disorder research: covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities. Editor(s): Beyer, Chad E.; Stahl, Stephen M. Num Pages: 150 pages, 27 b/w illus. 10 tables. BIC Classification: MMGW. Category: (P) Professional & Vocational. Dimension: 242 x 156 x 62. Weight in Grams: 454. . 2010. New. hardcover. . . . . …

Hardback. Condition: New. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.…

Condition: New.

Condition: New.

Condition: New. pp. 150.

Condition: New. The future of mood-disorder research: covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities. Editor(s): Beyer, Chad E.; Stahl, Stephen M. Num Pages: 150 pages, 27 b/w illus. 10 tables. BIC Classification: MMGW. Category: (P) Professional & Vocational. Dimension: 242 x 156 x 62. Weight in Grams: 454. . 2010. New. hardcover. . . . . Books ship from the US and Ireland. …

Condition: As New. Unread book in perfect condition.

Condition: As New. Unread book in perfect condition.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.…

Paperback. Condition: Brand New. 250 pages. 9.25x7.50x9.25 inches. In Stock.

Hardback. Condition: New. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.…

Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone i.…

Hardcover. Condition: new. Hardcover. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone involved in psychopharmacology development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Buch. Condition: Neu. Next Generation Antidepressants | Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders | Chad Beyer (u. a.) | Buch | Gebunden | Englisch | 2011 | Cambridge University Press | EAN 9780521760584 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. …

Condition: New. Print on Demand pp. 150 27 Illus.

Hardback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Condition: New. PRINT ON DEMAND pp. 150.